Korean study tracks new psoriasis Treatment's Real-World safety
NCT ID NCT06886009
Summary
This study aims to monitor the safety and effectiveness of spesolimab, an intravenous medication, in Korean patients experiencing severe flares of generalized pustular psoriasis. Researchers will observe 21 patients in routine medical practice to track side effects and how well the treatment clears skin pustules. The study focuses on real-world use after the medication's approval in Korea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ajou University Hospital
Suwon, 16499, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Asan Medical Center
Seoul, 05505, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pusan National University Yangsan Hospital
Busan, 49241, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Samsung Medical Center
Seoul, 06351, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.